Literature DB >> 16954500

Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

Mineo Iwata1, Manoj Pillai, Aravind Ramakrishnan, Robert C Hackman, H Joachim Deeg, Ghislain Opdenakker, Beverly Torok-Storb.   

Abstract

Regulatory molecules produced by stromal cells are often membrane bound until cleaved by matrix metalloproteinases (MMPs); cleavage can either activate or inactivate regulatory functions. We report here that marrow stromal cells induce the expression of MMP-9 in monocytes. Induction was contact independent and could be reproduced with recombinant MCP-1/CCL2, whereas IL-6, M-CSF, G-CSF, GM-CSF, IL-8/CXCL8, SDF-1/CXCL12, and MGSA/CXCL1 did not have this effect. Stroma-induced levels of MMP-9 in the monocyte population from healthy donors were relatively consistent, whereas induced levels varied significantly (P < .001) in the CD14+ population from 27 patients with myelodysplastic syndrome (MDS). In patients with a clonal chromosomal marker, the level of inducible MMP-9 expression in the monocyte population was inversely correlated with the percentage of marker-positive cells (n = 11, P = .01), suggesting that the ability to induce MMP-9 may be compromised in clonally derived monocytes. The inducible levels of MMP-9 were also inversely correlated with marrow cellularity observed in biopsies from MDS patients (P < .001). We conclude that monocytes can express MMP-9 in response to stromal factors and that this response may be significantly decreased in MDS-derived monocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16954500      PMCID: PMC1785081          DOI: 10.1182/blood-2006-05-020289

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8.

Authors:  S Masure; P Proost; J Van Damme; G Opdenakker
Journal:  Eur J Biochem       Date:  1991-06-01

2.  The essential cells of the hemopoietic microenvironment.

Authors:  T D Allen; T M Dexter
Journal:  Exp Hematol       Date:  1984-08       Impact factor: 3.084

3.  Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells.

Authors:  H E Broxmeyer; B Sherry; L Lu; S Cooper; K O Oh; P Tekamp-Olson; B S Kwon; A Cerami
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

4.  Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin.

Authors:  J L Seltzer; A Z Eisen; E A Bauer; N P Morris; R W Glanville; R E Burgeson
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

Authors:  S M Wilhelm; I E Collier; B L Marmer; A Z Eisen; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

6.  Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.

Authors:  G Opdenakker; S Masure; B Grillet; J Van Damme
Journal:  Lymphokine Cytokine Res       Date:  1991-08

7.  Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.

Authors:  M S Hibbs; J R Hoidal; A H Kang
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure.

Authors:  J P Maciejewski; J M Liu; S W Green; C E Walsh; M Plumb; I B Pragnell; N S Young
Journal:  Exp Hematol       Date:  1992-10       Impact factor: 3.084

9.  In vitro functions of stromal cells from human and mouse bone marrow.

Authors:  D Zipori; N Reichman; L Arcavi; M Shtalrid; A Berrebi; P Resnitzky
Journal:  Exp Hematol       Date:  1985-08       Impact factor: 3.084

10.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

Authors:  G I Goldberg; A Strongin; I E Collier; L T Genrich; B L Marmer
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more
  18 in total

1.  Functionally and phenotypically distinct subpopulations of marrow stromal cells are fibroblast in origin and induce different fates in peripheral blood monocytes.

Authors:  Mineo Iwata; Richard S Sandstrom; Jeffrey J Delrow; John A Stamatoyannopoulos; Beverly Torok-Storb
Journal:  Stem Cells Dev       Date:  2013-11-23       Impact factor: 3.272

2.  The role of the marrow microenvironment in hematopoietic stem cell transplantation.

Authors:  Aravind Ramakrishnan; Beverly J Torok-Storb
Journal:  Cell Ther Transplant       Date:  2010-04-01

Review 3.  The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.

Authors:  Kui-Wu Yao; Liang-Deng Zhang; Jie Wang
Journal:  Chin J Integr Med       Date:  2011-08-01       Impact factor: 1.978

4.  Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.

Authors:  Cesar A Meschiari; Mira Jung; Rugmani Padmanabhan Iyer; Andriy Yabluchanskiy; Hiroe Toba; Michael R Garrett; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-13       Impact factor: 4.733

Review 5.  Biology of BM failure syndromes: role of microenvironment and niches.

Authors:  Sophia R Balderman; Laura M Calvi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

6.  Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.

Authors:  A Mario Marcondes; Aravind Ramakrishnan; H Joachim Deeg
Journal:  Curr Cancer Ther Rev       Date:  2009-11-01

Review 7.  Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.

Authors:  Daniella B Kerbauy; H Joachim Deeg
Journal:  Exp Hematol       Date:  2007-11       Impact factor: 3.084

8.  Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Authors:  Sophia R Balderman; Allison J Li; Corey M Hoffman; Benjamin J Frisch; Alexandra N Goodman; Mark W LaMere; Mary A Georger; Andrew G Evans; Jane L Liesveld; Michael W Becker; Laura M Calvi
Journal:  Blood       Date:  2015-12-04       Impact factor: 22.113

Review 9.  A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease.

Authors:  Aravind Ramakrishnan; H Joachim Deeg
Journal:  Expert Opin Biol Ther       Date:  2009-01       Impact factor: 4.388

Review 10.  Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies.

Authors:  Xiaofang Chen; Ningyu Li; Jianyu Weng; Xin Du
Journal:  Front Cell Dev Biol       Date:  2021-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.